NEW YORK - Metastatic melanoma of the brain has a terrible prognosis, with a median survival of three to four months.
Combining Microneedling and Tranexamic Acid for Melasma: Efficacy and Satisfaction
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Xkin Suture Device Acts as Effective Wound Closure Method, Improves Scar Outcomes
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
Insights into Bimekizumab 2-Year Data for PsA, nr-asSpA, and AS
Physicians Should Prepare for Potential Acne Vulgaris Misinformation Correction, Report Says